Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.gendis.2020.11.005 http://scihub22266oqcxt.onion/10.1016/j.gendis.2020.11.005 33225036!7672332!33225036     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33225036&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Genes+Dis 2021 ; 8 (4): 484-492 Nephropedia Template TP {{tp|p=33225036|t=2021. Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury |pdf=|usr=}}{{33225036}} gab.com Text Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury JO: Genes Dis http://www.kidney.de/pget.php?&tw=1&pmid=33225036 #FOAvip To date, it remains unclear if severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection exacerbates liver injury in patients with chronic hepatitis B virus (HBV) infection. In this study, we present a retrospective study of 133 hospitalized confirmed mild coronavirus disease 2019 (COVID-19) cases, including 116 patients with COVID-19 with negative serum hepatitis B antigen and 17 HBV inactive carriers with COVID-19. We found that there were no significant differences for the discharge rate or duration of hospitalization between the two groups. However, inactive HBV carriers with SARS-CoV-2 co-infection are at a higher risk of abnormal liver function tests. The enhanced liver injury induced by SARS-CoV-2 and HBV co-infection was identified as the hepatocyte type rather than the cholangiocyte type. Moreover, the inflammatory response, including abnormal lactate dehydrogenase, D-dimer and interleukin-6 production, may contribute to this injury following SARS-CoV-2 co-infection. Collectively, SARS-CoV-2 and HBV co-infection exacerbates liver function of the patients with COVID-19. Twit Text FOAVip Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury ????Genes Dis http://www.kidney.de/pget.php?&tw=1&pmid=33225036 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33225036 #FOAvip English Wikipedia <ref>{{Cite pmid|33225036}}</ref> Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury #MMPMID33225036 Lin Y; Yuan J; Long Q; Hu J; Deng H; Zhao Z; Chen J; Lu M; Huang A Genes Dis 2021[Jul]; 8 (4): 484-492 PMID33225036show ga To date, it remains unclear if severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) co-infection exacerbates liver injury in patients with chronic hepatitis B virus (HBV) infection. In this study, we present a retrospective study of 133 hospitalized confirmed mild coronavirus disease 2019 (COVID-19) cases, including 116 patients with COVID-19 with negative serum hepatitis B antigen and 17 HBV inactive carriers with COVID-19. We found that there were no significant differences for the discharge rate or duration of hospitalization between the two groups. However, inactive HBV carriers with SARS-CoV-2 co-infection are at a higher risk of abnormal liver function tests. The enhanced liver injury induced by SARS-CoV-2 and HBV co-infection was identified as the hepatocyte type rather than the cholangiocyte type. Moreover, the inflammatory response, including abnormal lactate dehydrogenase, D-dimer and interleukin-6 production, may contribute to this injury following SARS-CoV-2 co-infection. Collectively, SARS-CoV-2 and HBV co-infection exacerbates liver function of the patients with COVID-19. ?Patients with SARS-CoV-2 and HBV co-infection are at risk of greater l(epmc).pdf DeepDyve Pubget Overpricing